Healthcare -
Biotechnology - NASDAQ - US
$ 5.95
-3.19 %
$ 964 M
Market Cap
-6.13
P/E
NVAX - REVENUE
Revenue NVAX - Novavax, Inc.
682 M
LAST VALUE
-34.68%
2 YEAR CAGR
105.39%
5 YEAR CAGR
36.37%
10 YEAR CAGR